Hanmi Pharm Co Ltd
Hanmi Pharm's GHG Emissions Data Preview
In 2023, Hanmi Pharm completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Hanmi Pharm has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Hanmi Pharm's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Hanmi Pharm amounted to 86,365 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Hanmi Pharm increased by 1.72%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Hanmi Pharm's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Hanmi Pharm's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Hanmi Pharm were 11,541 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Hanmi Pharm reduced its Scope 1 emissions over time?
Since 2021, Hanmi Pharm's Scope 1 emissions have increased by 17.3%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Hanmi Pharm's Scope 1 emissions increased by 7.06%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Hanmi Pharm's Scope 2 emissions?
In 2023, Hanmi Pharm reported Scope 2 greenhouse gas (GHG) emissions of 74,824 tCOâ‚‚e without specifying the calculation method.
Has Hanmi Pharm reduced its Scope 2 emissions over time?
Since 2021, Hanmi Pharm's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Hanmi Pharm 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Hanmi Pharm's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Hanmi Pharm 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Hanmi Pharm use for Scope 2 reporting?
In 2023, Hanmi Pharm reported its Scope 2 emissions using an unspecified methodology.
Hanmi Pharm's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Hanmi Pharm's Value Chain Emissions
In 2023, Hanmi Pharm reported 82,555 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Hanmi Pharm includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain
Hanmi Pharm's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Hanmi Pharm's Scope 3 emissions?
In 2023, Hanmi Pharm reported total Scope 3 emissions of 82,555 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 79.62% of these emissions originated from upstream activities such as purchased goods and capital goods, while 20.38% came from downstream activities like product use, distribution, and end-of-life treatment.
What categories of Scope 3 emissions does Hanmi Pharm disclose?
In 2023, Hanmi Pharm reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Hanmi Pharm's Scope 3 emissions?
In 2023, the largest contributors to Hanmi Pharm's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 46,552 tCOâ‚‚e (56.39%)
- Investments (Cat. 15): 16,821 tCOâ‚‚e (20.38%)
- Capital Goods (Cat. 2): 4,987 tCOâ‚‚e (6.04%)
Hanmi Pharm's Scope 3 Emissions by Categories
Insights into Hanmi Pharm's Total Carbon Footprint
In 2023, Hanmi Pharm reported a total carbon footprint of 168,920 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 98.96% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Hanmi Pharm's total carbon footprint was Scope 3 emissions, accounting for 48.87% of the company's total carbon footprint, followed by Scope 2 emissions at 44.3%.